Research overturns previous findings on potential Parkinson’s disease target

A new study has found a molecule hailed as a potential drug candidate for Parkinson’s disease is no longer an effective therapeutic option. The WEHI-led research has debunked over 10 years of research that suggested a specific ‘activator molecule’ could be used to enhance the activity of a protein linked to early-onset Parkinson’s disease, PINK1.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.